Cargando…
Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers
OBJECTIVE: To evaluate the diagnostic ability of magnetic resonance imaging (MRI) based radiomics and traditional characteristics to differentiate between Ovarian sex cord-stromal tumors (SCSTs) and epithelial ovarian cancers (EOCs). METHODS: We consecutively included a total of 148 patients with 17...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880468/ https://www.ncbi.nlm.nih.gov/pubmed/36713500 http://dx.doi.org/10.3389/fonc.2022.1073983 |
_version_ | 1784878918331793408 |
---|---|
author | Cheng, Meiying Tan, Shifang Ren, Tian Zhu, Zitao Wang, Kaiyu Zhang, Lingjie Meng, Lingsong Yang, Xuhong Pan, Teng Yang, Zhexuan Zhao, Xin |
author_facet | Cheng, Meiying Tan, Shifang Ren, Tian Zhu, Zitao Wang, Kaiyu Zhang, Lingjie Meng, Lingsong Yang, Xuhong Pan, Teng Yang, Zhexuan Zhao, Xin |
author_sort | Cheng, Meiying |
collection | PubMed |
description | OBJECTIVE: To evaluate the diagnostic ability of magnetic resonance imaging (MRI) based radiomics and traditional characteristics to differentiate between Ovarian sex cord-stromal tumors (SCSTs) and epithelial ovarian cancers (EOCs). METHODS: We consecutively included a total of 148 patients with 173 tumors (81 SCSTs in 73 patients and 92 EOCs in 75 patients), who were randomly divided into development and testing cohorts at a ratio of 8:2. Radiomics features were extracted from each tumor, 5-fold cross-validation was conducted for the selection of stable features based on development cohort, and we built radiomics model based on these selected features. Univariate and multivariate analyses were used to identify the independent predictors in clinical features and conventional MR parameters for differentiating SCSTs and EOCs. And nomogram was used to visualized the ultimately predictive models. All models were constructed based on the logistic regression (LR) classifier. The performance of each model was evaluated by the receiver operating characteristic (ROC) curve. Calibration and decision curves analysis (DCA) were used to evaluate the performance of models. RESULTS: The final radiomics model was constructed by nine radiomics features, which exhibited superior predictive ability with AUCs of 0.915 (95%CI: 0.869-0.962) and 0.867 (95%CI: 0.732-1.000) in the development and testing cohorts, respectively. The mixed model which combining the radiomics signatures and traditional parameters achieved the best performance, with AUCs of 0.934 (95%CI: 0.892-0.976) and 0.875 (95%CI: 0.743-1.000) in the development and testing cohorts, respectively. CONCLUSION: We believe that the radiomics approach could be a more objective and accurate way to distinguish between SCSTs and EOCs, and the mixed model developed in our study could provide a comprehensive, effective method for clinicians to develop an appropriate management strategy. |
format | Online Article Text |
id | pubmed-9880468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98804682023-01-28 Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers Cheng, Meiying Tan, Shifang Ren, Tian Zhu, Zitao Wang, Kaiyu Zhang, Lingjie Meng, Lingsong Yang, Xuhong Pan, Teng Yang, Zhexuan Zhao, Xin Front Oncol Oncology OBJECTIVE: To evaluate the diagnostic ability of magnetic resonance imaging (MRI) based radiomics and traditional characteristics to differentiate between Ovarian sex cord-stromal tumors (SCSTs) and epithelial ovarian cancers (EOCs). METHODS: We consecutively included a total of 148 patients with 173 tumors (81 SCSTs in 73 patients and 92 EOCs in 75 patients), who were randomly divided into development and testing cohorts at a ratio of 8:2. Radiomics features were extracted from each tumor, 5-fold cross-validation was conducted for the selection of stable features based on development cohort, and we built radiomics model based on these selected features. Univariate and multivariate analyses were used to identify the independent predictors in clinical features and conventional MR parameters for differentiating SCSTs and EOCs. And nomogram was used to visualized the ultimately predictive models. All models were constructed based on the logistic regression (LR) classifier. The performance of each model was evaluated by the receiver operating characteristic (ROC) curve. Calibration and decision curves analysis (DCA) were used to evaluate the performance of models. RESULTS: The final radiomics model was constructed by nine radiomics features, which exhibited superior predictive ability with AUCs of 0.915 (95%CI: 0.869-0.962) and 0.867 (95%CI: 0.732-1.000) in the development and testing cohorts, respectively. The mixed model which combining the radiomics signatures and traditional parameters achieved the best performance, with AUCs of 0.934 (95%CI: 0.892-0.976) and 0.875 (95%CI: 0.743-1.000) in the development and testing cohorts, respectively. CONCLUSION: We believe that the radiomics approach could be a more objective and accurate way to distinguish between SCSTs and EOCs, and the mixed model developed in our study could provide a comprehensive, effective method for clinicians to develop an appropriate management strategy. Frontiers Media S.A. 2023-01-13 /pmc/articles/PMC9880468/ /pubmed/36713500 http://dx.doi.org/10.3389/fonc.2022.1073983 Text en Copyright © 2023 Cheng, Tan, Ren, Zhu, Wang, Zhang, Meng, Yang, Pan, Yang and Zhao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Cheng, Meiying Tan, Shifang Ren, Tian Zhu, Zitao Wang, Kaiyu Zhang, Lingjie Meng, Lingsong Yang, Xuhong Pan, Teng Yang, Zhexuan Zhao, Xin Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers |
title | Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers |
title_full | Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers |
title_fullStr | Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers |
title_full_unstemmed | Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers |
title_short | Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers |
title_sort | magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880468/ https://www.ncbi.nlm.nih.gov/pubmed/36713500 http://dx.doi.org/10.3389/fonc.2022.1073983 |
work_keys_str_mv | AT chengmeiying magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers AT tanshifang magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers AT rentian magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers AT zhuzitao magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers AT wangkaiyu magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers AT zhanglingjie magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers AT menglingsong magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers AT yangxuhong magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers AT panteng magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers AT yangzhexuan magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers AT zhaoxin magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers |